Jan-Henning Klusmann

31PUBLICATIONS
237CO-AUTHORS
Haematological tumoursMolecular targetsHaematologyRespiratory diseasesInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Oct 06, 2026
A platform of serially transplantable AML PDX models covering subgroups for which no cell lines exist.

|Jul 10, 2026
The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers.

|Jul 01, 2026
Lineage-restricted dependency on an oncofetal SNHG29-IGF2BP1 RNA axis in acute megakaryoblastic leukemia.

|Apr 07, 2026
DLK1 is a GATA1s-driven dependency and therapeutic target in Down syndrome-associated myeloid leukemia.

Lonneke Verboon, Sonali P Barwe, Meredith Tavenner

|Apr 06, 2026
First-in-Human Study of IL15-Activated Cytokine-Induced Killer Cells After Allogeneic HCT Shows Durable Remission and Serotherapy-Associated Immune Reconstitution in Leukemia.

Eva Rettinger, Dirk Heckl, Martin Hutter

|Oct 21, 2025
CPX-351 in Down syndrome-associated myeloid leukemia: results and prognostic factors from the phase 3 ML-DS 2018 trial.

Stephanie Laszig, Antonia Diederichs, Emilia Salzmann-Manrique

Pageof 6

Frequent Collaborators

5 joint publications

Dirk Reinhardt

5 joint publications

Raj Bhayadia

3 joint publications

Ruth Witt

3 joint publications

Bianca Goemans